[vc_row row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” header_style=”” parallax_content_width=”in_grid” anchor=”” in_content_menu=”” content_menu_title=”” content_menu_icon=”” angled_section=”no” angled_section_position=”both” angled_section_direction=”from_left_to_right” text_align=”left” video=”” video_overlay=”” video_overlay_image=”” video_webm=”” video_mp4=”” video_ogv=”” video_image=”” background_image=”” background_image_as_pattern=”without_pattern” section_height=”” parallax_speed=”” background_color=”” border_color=”” row_negative_margin=”” side_padding=”” parallax_side_padding=”” padding_top=”” padding_bottom=”” color=”” hover_color=”” more_button_label=”” less_button_label=”” button_position=”” css_animation=”” transition_delay=””][vc_column width=”1/1″][vc_empty_space height=”32px” background_image=”” image_repeat=”no-repeat”][vc_column_text]
[/vc_column_text][vc_column_text]
Download the Final programme in PDF and
the Book of abstracts (password was sent to you by email).
[/vc_column_text][vc_empty_space height=”32px” image_repeat=”no-repeat”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]P1 – Investigating the Mg2+ cations influence on the formation of RNA Kissing complexes
Josephine Abi-Ghanem1,2,3, Clémence Rabin1,2,3, Massimiliano Porrini1,2,3, Valérie Gabelica1,2,3
P2 – From DNA Computation to Aptamer Selection: Beyond the Hopfield approximation.
Dr. Jean-Pierre Aimé, Dr Juan Elezgaray.
P3 – Aptaswitches: new supramolecular tools
P4 – Targeted anticancer therapy using bioconjugates of magnetic nanoparticles with DNA-aptamers
Irina.V. Belyanina1,2,3, Anna Zamay1,2, Galina S. Zamay1,2, Yury E. Glazyrin2, Olga S. Kolovskaya1,2, Taiana Ivanchenko1, Dmitry Veprincev1,2, Alexey E. Sokolov1, Valery Denisenko1, Sergey Zamay1, Maxim Berezovski4, scientific adviser dr. Tatiana N. Zamay
P5 – Development of synthetic riboswitches.
Adrien Boussebayle, Thea Lotz, Beatrix Süß.
P6 – An Aptamer-Based Diagnostic Test Specific for Falciparum Malaria
Yee-Wai Cheung1, Roderick M. Dirkzwager1, Josiane Cardoso2, Alvin Wai-Chung Wong1 and Julian A. Tanner1
P7 – RNA aptamers as ligands of integrin alpha5 beta1
Marine Fenat1, Pierre Fechter2, Nelly Etienne-Selloum1, Isabelle Lelong-Rebel1, Sophie Martin1, Maxime Lehmann1, Monique Dontenwill1 & Laurence Choulier1
P8 – ELAKCA: Enzyme-Linked Aptamer Kissing Complex Assay as a Small Molecule Sensing Platform
Benoit Chovelon,1,2 Guillaume Durand,3 Eric Dausse,3 Jean-Jacques Toulmé,3 Patrice Faure,2,4 Eric Peyrin1* and Corinne Ravelet1*
P9 – Near infrared fluorescent imaging for aptamers biodistribution
Ioanna Theodorou1,2, Chloé Dambrune1,2, Nam Nguyen Quang1,2, Benoit Lelandais1,2, Frederic Ducongé1,2
P10 – Identification of DNA kissing complexes.
Eric Dausse, Nicolas J. Tourasse and Jean-Jacques Toulmé
P11 – Riboswitches based on kissing complexes for the detection of small ligands
Durand Guillaume1,2, Eric Dausse2, Corinne Ravelet3, Eric Peyrin3, Jean-Jacques Toulmé2,4
P12 – Riboswitch – Small Molecule Interactions Analyzed with the switchSENSE Platform
Felix Kroener1,2, Christopher Schneider3, Florian Groher3, Beatrix Süß3, Wolfgang Kaiser1
P13 – A novel internalizing Aptamer Targeting Insulin Receptor
Margherita Iaboni 1,4, Raffaela Fontanella2, Anna Rienzo3, Maria Capuozzo3, Nuzzo S.1, 3, Silvia Catuogno3, Gerolama Condorelli 1,3, Vittorio de Franciscis3, Carla Lucia Esposito3
P14 – Single cell-level microsurgery using aptamer functionalized magnetic microdiscs for tumor eradicationIrina Garanzha, a,c, Anna Zamaya,b, Galina S. Zamaya,b, Yury E. Glazyrinb, Olga S. Kolovskayaa,b, Alexandr Shabanova, Viktor Y. Prinze, Vladimir Selezneve, Tatiana Ivanchenkob, Dmitry Veprinceva,b, Alexey E. Sokolova, Valery Denisenkoa, Sergey Zamaya, Ana Gargaund, Maxim Berezovskid, scientific adviser dr. Tatiana N. Zamay
P15 – Colorimetric small molecules sensing using a structure switching strategy on modified gold nanoparticles
Emma Goux1, Valérie Guieu1*, Luc Choisnard1, Guillaume Durand2, Eric Dausse2, Jean-Jacques Toulmé2, Corinne Ravelet1 and Eric Peyrin1
P16 – Kinetic analysis of the different candidate RNA aptamers-protein interactions
Nathalie Vollmer1, Karen Mercier1, Fatima-Ezzahra Hibti1, Xianbin Yang2, Mark Shumbera2, Marinella Sandros3, Chiraz Frydman1
P17 – Subtractive cell SELEX for DNA aptamers binding to a human leukemia cell line.
NA Kacherovsky1, BR Olden1, SJ Salipante2, MC Jensen3, SH Pun1
P18 – Nuclease-Activated Oligonucleotide Probes for the Rapid and Robust Detection of Breast Cancer Circulating Tumor Cells (CTCs)
Sven Kruspe1, David D. Dickey1, William H. Thiel1, Karen C. Clark1, Kevin Urak2, Elliot Burghardt1, Justin P. Dassie1, Alexandra Thomas1, James O. McNamara II1,2, Paloma H. Giangrande1,2,3.
P19 – Quantification of non-coding RNAs in bacterial cells
using a Broccoli aptamer
Charlotte Hardion, Alexandre Dawid, Stéphan Lacour
P20 – The skin: a novel field for therapeutic aptamers
Thomas Lettner, Julia Reichelt, Verena Wally.
P21 – Development of aptamer-based electrochemical sensing system for monitoring luteinizing hormone pulsatility
Shaolin Liang1, 2, Waljit Dhillo2, Anthony E G Cass3 and Julian A Tanner1
P22 – Aptamers Binding To Bradykinin
Ricardo Lima Pereira, Arquimedes Cheffer, Claudiana Lameu, Ana Paula Santos, Henning Ulrich
P23 – CE-non-SELEX for the isolation of aptamers directed against the tau protein.
Samuele Lisi1,2, Emmanuelle Fiore1, Yannik Boehmann3, Simona Scarano2, Maria Minunni2, Eric Peyrin1, Corinne Ravelet1
P24 – Experimental conditions affect apparent affinity of thrombin-binding DNA aptamers
Kepler Mears1, Delia J. Scoville1, Rebecca J. Whelan1
P25 – MicroScale Thermophoresis: Interaction Analysis and beyond
Moran Jerabek-Willemsen, Timon André, Randy Wanner, Heide Marie Roth, Stefan Duhr, Philipp Baaske, Dennis Breitsprecher
P26 – Identification of Stem Cell Lung Cancer by DNA Aptamers
Isis C. Nascimento1, Jan Mavri2, Tina Smuc2, Arthur A. Nery1, Tamara T. Lah3, Matjaz Peterka2, Henning Ulrich1
P27 – Selection of Specific, Slow Off-rate Modified Aptamer (SOMAmer®) Reagents for the Highly Similar Proteins GDF-11 and GDF-8
Urs Ochsner1, Louis Green1, Taylor Rice1, and Nebojsa Janjic1
P28 – An RNA aptamer that binds the glycolytic flux-signaling metabolite
Fructose-1,6-bisphosphate.
Alvaro D. Ortega1, Yi Long2, Neus Mestre-Farràs1, Franziska Pfeiffer3, Günter Mayer3, Lars Folke Olsen2, Matthias Heinemann1.
P29 – Targeting CD28 costimulation with bi-specific aptamers to melanoma chemotherapy resistant cancer stem cells.
Mario M Soldevilla1,2, Helena Villanueva1,2, Noelia Casares2,3, Juan J Lasarte2,3, Maurizio Bendandi4, Susana Inoges2,5, Ascension López-Díaz de Cerio2,5, Fernando Pastor1,2.
P30 – Preclinical trials of novel anticoagulant — DNA aptamer Trombiveb®.
Galina V. Pavlova1,2, Alexey M. Kopylov1,3, Askar D. Turashev1, Nadezhda S. Samoylenkova1,2, Elena G. Zavyalova1,3, Alexander V. Revishchin2, Andrey V. Golovin1,4.
P31 – Biophysical characterization of RNA-metabolite complexes by native MS
Stefano Piccolo 1,2,3 et Valérie Gabelica 1,2,3
P32 – Semi-automated binding of aptamers on adherent living cells
Nam Nguyen Quang1, 2, Carine Pestourie3, Agnès Cibiel4 & Frédéric Ducongé1, 2,*
P33 – PATTERNITY-seq: high-throughput analysis of sequence patterns and paternity relationship between them during molecular evolution processes.
Nam Nguyen Quang1,2, Clément Bouvier1,2, Benoit Lelandais1,2 and Frédéric Ducongé1,2.
P34 – A native MS Study of RNA kissing complexes and their interaction with magnesium cations
Clémence Rabin 1,2,3, Adrien Marchand1,2,3, Joséphine Abi-Ghanem1,2,3 & Valérie Gabelica1,2,3
P35 – Functional neutralization of αC-conotoxin PrXA by aptamers
Tarek Mohamed Abd El Aziz1, 3, Corinne Ravelet2* , Emmanuelle Fiore2 , Germain Sotoing Taiwe5, Michel Ronjat1, Jerôme Dejeu4, Eric Peyrin2, , Michel De Waard1, 6
P36 – Aptamers for identification and purification of mesenchymal stem cells
Ana Paula Santos1 ; Arthur A. Nery1 ; Henning Ulrich1
P37 – Selection of aptamers against the norovirus protruding domain in presence of four different food matrices
Katja Schilling1,2, Jacquelina Woods2
P38 – Characterization of aptaswitch complexes by MicroScale Thermophoresis.
Thomas Schubert1 , Eric Dausse2, Kniep Lukas1, Guillaume Durand2, Jean-Jacques Toulmé2.
P39 – Selecting DNA Aptamers for the Ovarian Cancer Biomarker CA125
Delia Scoville1, Tae Kyu Brian Uhm1, Jamie Shallcross1, Rebecca Whelan1
P40 – Aptamer-Mediated Macromolecular Recognitionin Facilitating DNA Tweezer Machinery
Simon Chi-Chin Shiu, Yee-Wai Cheung, Roderick M. Dirkzwager, Shaolin Liang,
Andrew B. Kinghorn, Lewis A. Fraser, Marco S. L. Tang and Julian A. Tanner
P41 – Efficient Cell-SELEX using engineered isogenic cell lines to generate RNA aptamer against a cell surface protein of interest
Masaki Takahashi1, Yoshifumi Hashimoto1, Eri Sakota1, Yoshikazu Nakamura1,2
P42 – Aptamer-gated DNA origami nanobox for malaria detection
Marco S. L. Tang1, Maia Godonoga2, Andrew B Kinghorn1, Yee-Wai Cheung1, Jonathan Heddle3
and Julian A. Tanner1
P44 – Control of pre-mRNA splicing by the tetracycline aptamer
Marc Vogel1, Julia E. Weigand1, Beatrix Süß1
P45 – Multiplex aptamer-based electrochemical sensor for lung cancer detection.
Galina S. Zamay1,2, Yury E. Glazyrin1,2, Tatiana N. Zamay1, Vasilii A. Kolovsky7, Alexandr V. Shabanov3, Dmitry V. Veprintsev1, Alexey V. Krat4, Sergey S. Zamay3, Olga S. Kolovskaya1, Ana Gargaun6, Alexey E. Sokolov5, Andrey A. Modestov4, Ivan P. Artyukhov1, Nikolay V. Chesnokov2, Marina M. Petrova1, Maxim V. Berezovski6, Anna S. Zamay*1,2
P46 – Selective elimination of tumor cells in vivo using laser induced plasmon resonance of aptamer functionalized gold nanoparticles
Tatiana. N Zamaya,b, Irina.V. Belyaninab,d, Alexandr Alexandrovskiia, Alexey E. Sokolova, Dubinina Annaa, Galina S. Zamaya,b, Irina Garanzhad, Yury E. Glazyrinb, Olga S. Kolovskayab, Tatiana Ivanchenkob, Natalia Chanchikovac, Nikolay Tokarevc, Nikolay Shepelivichc, Elena Karlovac, Anastasia Ozerskayac, Evgeniy Badrinc, Kirill Beluginc, Semion Belkinc ,Vladimir Zabludaa, Maxim Berezovskie, Anna Zamayb
P47 – INTERFERING WITH THE PROLIFERATION OF PLASMODIUM FALCIPARUM BY CELL-SELEX
Flávia Zimbres1, Henning Ulrich2, Carsten Wrenger1
P48 – Generating aptamers capable of binding small molecular targets and refining the target binding characteristics
Shalen Kumar1,2, Shiwei Li1,2, Jeremy Jones1, Doug C. Eckery3, Janet Pitman1 and Kenneth P. McNatty1
P49 – Identification of glioblastoma stem-like cells by DNA aptamers
Erika de S. Molina1, Tiago Sobreira2, Marina Trombetta-Lima3, Lucas Nishida1, Maria Elisa Goes1, Attila Tárnok4, Heidrun Holland4, Isis C. Nascimento1, Mari Cleide Sogayar3, Henning Ulrich1
P50 – Use of aptamers as antitumor agents based on Cell Selex methodology for prostate cancer
Aline Moreira1, Anael Alberto1, Helena Magalhães1, Leila Mendonça1, Etel Gimba2, Martin Bonamino3,4, Wim Degrave1 and Mariana Waghabi1
P51 – Conditional aptaswitch interaction.
Lorena Zara1, Eric Dausse1, and Jean-Jacques Toulmé1,2
P52 – Switch Aptamers-Based Analysis: A Promising Alternative for Mycotoxins Detection
Gaëlle Catanante1, Atul Sharma2, K. Yugender Goud3, and Jean-Louis Marty1
P53 – Aptamer selection by microfluidic recovery coupled with SPR detection
Carmelo Di Primo1,2, Eric Dausse1,2, Aurélien Barré3, Alain Rico4, Emilie Daguerre1,2, Gilmar Salgado1,2, Macha Nikolski3 and Jean-Jacques Toulmé1,2
P54 – Just in Time-Selection: A semiautomated two-step method for in vitro selection of DNA aptamers
Fischer
P55 – Tunable Cytotoxic Agents for the Treatment of Prostate Cancer
Bethany Powell Gray1, Linsley Kelly2, Jessica McDade1, Matthew Levy2, and Bruce A. Sullenger1,3
P56 – Fluid Biopsy Allowing Lung Cancer Diagnosis via Aptamer Based CTC Detection
V.L. Grigoreva1,3, Galina S. Zamay1,2, Anna Zamay1,2 , Yury E. Glazyrin2, Olga S. Kolovskaya1,2, Alexey V Krat1,2, Irina Garanzha1,3, Ana Gargaun4, Marina Petrova2, Ivan Artyukhov2, Maxim Berezovski4, scientific adviser dr. Tatiana N. Zamay
P57 – Active and Exo-site Inhibition of Factor Xa by RNA Aptamer-Drug Pairs for Potent, Reversible Anticoagulation
Ruwan Gunaratne1, James Frederiksen1, Michelle D. Ho2, Nabil K. Thalji2, Rodney M. Camire2, and Bruce A. Sullenger1
P58 – Small-Molecule Detection and Enantiopurity Measurement Using DNA-Based Sensors.
Jennifer Heemstra1, Trevor Feagin1, Amberlyn Peterson1, and Zhesen Tan1
P59 – Expanding the Chemical Diversity of DNA
Chun Guo1, Dehui Kong1, Yi Lei1, and Ryan Hili1
P60 – DNA-aptamers as synthetic molecular probes for staining of abnormal blood vessels and tumor cells in lung cancer tissue sections
Olga S. Kolovskaya1,2, Galina S. Zamay1,2, Tatiana Ivanchenko2, Tatiana N. Zamay1, Valentina Grigorieva1, Maxim V. Berezovski3, and Anna S. Zamay1,2
P61 – Fitness Landscapes of Functional RNAs
Ádám Kun1,2,3 and Eörs Szathmáry1,3,4
P62 – FNA fluorescence reporting within silica-zirconia porous thin films
Marine Le Goas1, Nina Landreau1, Valérie Guieu2, Corinne Ravelet2, Eric Peyrin2, Serge Palacin1 and Laurent Mugherli1
P63 – Asymmetric inhibition of a small chiral molecule/aptamer binding reaction upon aptamer modification: a kinetic study using rotating droplet electrochemistry
Lylian Challier1‡, Rebeca Miranda-Castro1‡, Claire Fave2, Benoît Limoges2, François Mavré2, and Vincent Noël1
P64 – Selection of DNA aptamers from libraries of G-rich sequences as potential therapeutic agents in HMGB1-related pathologies
Domenica Musumeci1,3, Carla L. Esposito2, Giovanni N. Roviello3, Angela Coppola1, Vittorio De Franciscis2, Claudia Riccardi1, Chiara Platella1, and Daniela Montesarchio1
P65 – Ultrasensitive and rapid detection combining aptamers and isothermal recombinase polymerase amplification
Miriam Jauset-Rubio1, Markéta Svobodová1, Teresa Mairal1, Mohammad S. El-Shahawi3, Abdulaziz S. Bashammakh 3, Abdulrahman O. Alyoubi3, and Ciara K. O´Sullivan 1,3
P66 – Small Molecule Aptamer Assays Based on Fluorescence Anisotropy Signal-Enhancer Oligonucleotides
Sandrine Perrier, Prisca Bouilloud, Gisella De Oliveira Coelho, Mickael Henry and Eric Peyrin
P67 – Strategy of enhanced fluorescence polarization based on aptamer – protein anchor complexes for sensitive and rapid detection of ochratoxin A
Irina V. Safenkova1, Alexey V. Samokhvalov1, Sergei A. Eremin2, Anatoly V. Zherdev1, and Boris B. Dzantiev1
P68 – Targeting Structured RNAs via Cross-Chiral Recognition
Jonathan T. Sczepanski1
P69 – Development of an Antidote-Controlled RNA Probe for Molecular Thrombi Imaging
Kady-Ann Steen-Burrell1, Bethany Powell Gray1, and Bruce Sullenger1[/vc_column_text][/vc_column][/vc_row]